Labcorp declares quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 12, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 13, 2023 , to stockholders of record as

Tom Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit

Mr. Pike Brings 30 Years of Industry Experience and a Proven Track Record of Driving Growth 

Labcorp to speak at the 41st annual J.P. Morgan Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 3, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10 at 4:30 p.m.

Advancing the health of underserved populations: How a lab can support community health initiatives

To learn more, watch the NAACOS webinar, featuring Linda Fraunhofer, Director of Population Health Initiatives at Labcorp.